Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients. / Haugaard, Steen B; Andersen, Ove; Hales, CN; Halsall, I; Rosenfalck, AM; Iversen, Johan; Madsbad, Sten.

I: European Journal of Clinical Investigation, Bind 36, 2006, s. 436-445.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Haugaard, SB, Andersen, O, Hales, CN, Halsall, I, Rosenfalck, AM, Iversen, J & Madsbad, S 2006, 'Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients', European Journal of Clinical Investigation, bind 36, s. 436-445. https://doi.org/10.1111/j.1365-2362.2006.01640.x

APA

Haugaard, S. B., Andersen, O., Hales, CN., Halsall, I., Rosenfalck, AM., Iversen, J., & Madsbad, S. (2006). Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients. European Journal of Clinical Investigation, 36, 436-445. https://doi.org/10.1111/j.1365-2362.2006.01640.x

Vancouver

Haugaard SB, Andersen O, Hales CN, Halsall I, Rosenfalck AM, Iversen J o.a. Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients. European Journal of Clinical Investigation. 2006;36:436-445. https://doi.org/10.1111/j.1365-2362.2006.01640.x

Author

Haugaard, Steen B ; Andersen, Ove ; Hales, CN ; Halsall, I ; Rosenfalck, AM ; Iversen, Johan ; Madsbad, Sten. / Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients. I: European Journal of Clinical Investigation. 2006 ; Bind 36. s. 436-445.

Bibtex

@article{a4bb121b8c9040249361ad81ae85bccc,
title = "Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients",
abstract = "BACKGROUND: We aimed to investigate whether the insulin precursors, intact (IP) and 32-33 split proinsulin (SP), which are elevated in states of insulin resistance and predict type 2 diabetes, would be elevated in human immunodeficiency virus (HIV)-infected patients with lipodystrophy (LIPO). MATERIALS AND METHODS: Forty-three normoglycaemic HIV-infected patients [18 LIPO and 18 without lipodystrophy (NONLIPO) receiving antiretroviral drugs, and seven patients na{\"i}ve to antiretroviral drugs (NAIVE)] were examined. Insulin precursors were measured during fasting, during an intravenous glucose tolerance test and during a hyperinsulinaemic-euglycaemic clamp, respectively. Insulin secretion rates (ISR) were determined by deconvolution of C-peptide concentrations. Disposition index (DI) was calculated as insulin sensitivity (Si(RD)) multiplied by the first-phase insulin response to intravenous glucose. RESULTS: LIPO exhibited increased fasting IP and SP (P < 0.05), a higher proportion of elevated fasting IP (3.1 pmol L(-1), 66% vs. 33% and 28%, P < 0.05) and SP (7.2 pmol L(-1), 50%, 11% and 0%, P < 0.01), reduced Si(RD) (> 50%, P < 0.001) and increased ISR (P < 0.001) compared with NONLIPO and NAIVE. Fasting SP and IP correlated positively with ISR (P < 0.001) and inversely and hyperbolically with Si(RD) (P < 0.001). Fasting SP/insulin ratio correlated inversely with Si(RD) (P < 0.05). Incremental IP + SP/insulin ratio after an intravenous glucose bolus correlated inversely with DI (P < 0.01), but did not differ between study groups. CONCLUSIONS: Proinsulin appeared to be increased in HIV-lipodystrophy, but no more than caused by the increased ISR. Nevertheless, the inverse correlations between SP/insulin ratio versus Si(RD) and incremental total proinsulin/insulin ratio versus DI may argue for a subtle beta-cell dysfunction in those patients with insulin resistance and low DI.",
author = "Haugaard, {Steen B} and Ove Andersen and CN Hales and I Halsall and AM Rosenfalck and Johan Iversen and Sten Madsbad",
year = "2006",
doi = "http://dx.doi.org/10.1111/j.1365-2362.2006.01640.x",
language = "English",
volume = "36",
pages = "436--445",
journal = "Zeitschrift fur klinische Medizin",
issn = "0014-2972",
publisher = "Wiley-Blackwell",

}

RIS

TY - JOUR

T1 - Hyperproinsulinaemia in normoglycaemic lipodystrophic HIV-infected patients

AU - Haugaard, Steen B

AU - Andersen, Ove

AU - Hales, CN

AU - Halsall, I

AU - Rosenfalck, AM

AU - Iversen, Johan

AU - Madsbad, Sten

PY - 2006

Y1 - 2006

N2 - BACKGROUND: We aimed to investigate whether the insulin precursors, intact (IP) and 32-33 split proinsulin (SP), which are elevated in states of insulin resistance and predict type 2 diabetes, would be elevated in human immunodeficiency virus (HIV)-infected patients with lipodystrophy (LIPO). MATERIALS AND METHODS: Forty-three normoglycaemic HIV-infected patients [18 LIPO and 18 without lipodystrophy (NONLIPO) receiving antiretroviral drugs, and seven patients naïve to antiretroviral drugs (NAIVE)] were examined. Insulin precursors were measured during fasting, during an intravenous glucose tolerance test and during a hyperinsulinaemic-euglycaemic clamp, respectively. Insulin secretion rates (ISR) were determined by deconvolution of C-peptide concentrations. Disposition index (DI) was calculated as insulin sensitivity (Si(RD)) multiplied by the first-phase insulin response to intravenous glucose. RESULTS: LIPO exhibited increased fasting IP and SP (P < 0.05), a higher proportion of elevated fasting IP (3.1 pmol L(-1), 66% vs. 33% and 28%, P < 0.05) and SP (7.2 pmol L(-1), 50%, 11% and 0%, P < 0.01), reduced Si(RD) (> 50%, P < 0.001) and increased ISR (P < 0.001) compared with NONLIPO and NAIVE. Fasting SP and IP correlated positively with ISR (P < 0.001) and inversely and hyperbolically with Si(RD) (P < 0.001). Fasting SP/insulin ratio correlated inversely with Si(RD) (P < 0.05). Incremental IP + SP/insulin ratio after an intravenous glucose bolus correlated inversely with DI (P < 0.01), but did not differ between study groups. CONCLUSIONS: Proinsulin appeared to be increased in HIV-lipodystrophy, but no more than caused by the increased ISR. Nevertheless, the inverse correlations between SP/insulin ratio versus Si(RD) and incremental total proinsulin/insulin ratio versus DI may argue for a subtle beta-cell dysfunction in those patients with insulin resistance and low DI.

AB - BACKGROUND: We aimed to investigate whether the insulin precursors, intact (IP) and 32-33 split proinsulin (SP), which are elevated in states of insulin resistance and predict type 2 diabetes, would be elevated in human immunodeficiency virus (HIV)-infected patients with lipodystrophy (LIPO). MATERIALS AND METHODS: Forty-three normoglycaemic HIV-infected patients [18 LIPO and 18 without lipodystrophy (NONLIPO) receiving antiretroviral drugs, and seven patients naïve to antiretroviral drugs (NAIVE)] were examined. Insulin precursors were measured during fasting, during an intravenous glucose tolerance test and during a hyperinsulinaemic-euglycaemic clamp, respectively. Insulin secretion rates (ISR) were determined by deconvolution of C-peptide concentrations. Disposition index (DI) was calculated as insulin sensitivity (Si(RD)) multiplied by the first-phase insulin response to intravenous glucose. RESULTS: LIPO exhibited increased fasting IP and SP (P < 0.05), a higher proportion of elevated fasting IP (3.1 pmol L(-1), 66% vs. 33% and 28%, P < 0.05) and SP (7.2 pmol L(-1), 50%, 11% and 0%, P < 0.01), reduced Si(RD) (> 50%, P < 0.001) and increased ISR (P < 0.001) compared with NONLIPO and NAIVE. Fasting SP and IP correlated positively with ISR (P < 0.001) and inversely and hyperbolically with Si(RD) (P < 0.001). Fasting SP/insulin ratio correlated inversely with Si(RD) (P < 0.05). Incremental IP + SP/insulin ratio after an intravenous glucose bolus correlated inversely with DI (P < 0.01), but did not differ between study groups. CONCLUSIONS: Proinsulin appeared to be increased in HIV-lipodystrophy, but no more than caused by the increased ISR. Nevertheless, the inverse correlations between SP/insulin ratio versus Si(RD) and incremental total proinsulin/insulin ratio versus DI may argue for a subtle beta-cell dysfunction in those patients with insulin resistance and low DI.

U2 - http://dx.doi.org/10.1111/j.1365-2362.2006.01640.x

DO - http://dx.doi.org/10.1111/j.1365-2362.2006.01640.x

M3 - Journal article

VL - 36

SP - 436

EP - 445

JO - Zeitschrift fur klinische Medizin

JF - Zeitschrift fur klinische Medizin

SN - 0014-2972

ER -

ID: 34068086